Earnings History Data for Ampio Pharmaceuticals, Inc. (AMPE) - NYSE NASDAQ
To lookup another company type a stock symbol and press 'Go'. The overview will show the earnings release info that is available in TheStockCatalyst database for the company.
For historic stock the Extended Hours price data shown are from just before market open on the day of release for premarket earnings releases and of the day after release for afterhours earnings releases. The normal price data is from just before market close on the days of release for premarket releases and the day after release for afterhours releases.
For historic stock the Extended Hours price data shown are from just before market open on the day of release for premarket earnings releases and of the day after release for afterhours earnings releases. The normal price data is from just before market close on the days of release for premarket releases and the day after release for afterhours releases.
See the full list of available companies here.
Ampio Pharmaceuticals, Inc.
Ampio Pharmaceuticals, Inc. develops proprietary drugs for metabolic disease, eye disease, kidney disease, inflammation, CNS disease, and male sexual dysfunction. Principal products offered by the Company include Optina, an oral drug for the treatment of diabetic retinopathy and macular edema; and Vasaloc, an oral drug for the treatment of diabetic nephropathy. Ampio Pharmaceuticals, Inc. is based in Greenwood Village, Colorado.
Release Date | Time | Est. Time | Symbol | Name | Market Cap (M) | Rep. EPS | Est. EPS | Last years EPS | SeekingAlpha Headline | Price | Change | Ext. Hours Price | Ext. Hours Change | 52 Week Range | Volume | Avg. Volume | Ext. Hours Volume | Top Mover |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
16-05-2022 | AH | 4:10 PM ET (May 16) |
AMPE | Ampio Pharmaceuticals | 48.00 | -0.03 | -0.02 | 0.00 | Ampio Pharmaceuticals GAAP EPS of -$0.03 misses by $0.01 [5/16/2022 4:44 PM] |
0.1962 | -0.01 (-3.61%) |
0.17 | -0.04 (-17.40%) |
0.17 - 2.00 | 5,764,450 | 2,060,000 | 641,556 | |
|
||||||||||||||||||
29-03-2022 | AH | 4:00 PM ET (Mar 29) |
AMPE | Ampio Pharmaceuticals, Inc. | 115.93 | -0.04 | -0.02 | -0.02 | Ampio Pharmaceuticals GAAP EPS of -$0.10 [3/29/2022 4:19 PM] |
0.46 | -0.02 (-4.17%) |
0.47 | -0.01 (-1.25%) |
0.39 - 2.00 | 2,051,971 | 4,680,000 | 254,432 | |
10-11-2021 | AH | 4:00 PM ET (Nov 10) |
AMPE | Ampio Pharmaceuticals, Inc. | 322.74 | -0.02 | -0.02 | -0.02 | Ampio Pharmaceuticals EPS in-line [11/10/2021 4:03 PM] |
1.38 | -0.15 (-10.06%) |
1.34 | -0.20 (-12.99%) |
0.77 - 2.98 | 1,880,407 | 830,000 | 84,016 | |
04-08-2021 | AH | 4:00 PM ET (Aug 4) |
AMPE | Ampio Pharmaceuticals, Inc. | 267.71 | -0.02 | -0.02 | -0.02 | Ampio Pharmaceuticals EPS in-line [8/4/2021 4:10 PM] |
1.42 | 0.21 (17.49%) |
1.34 | 0.13 (10.74%) |
0.62 - 2.98 | 5,452,227 | 1,480,000 | 127,254 | |
05-05-2021 | AH | 4:00 PM ET (May 5) |
AMPE | Ampio Pharmaceuticals, Inc. | 361.91 | -0.02 | -0.02 | -0.04 | Ampio Pharmaceuticals EPS in-line [5/5/2021 4:09 PM] |
1.70 | -0.10 (-5.56%) |
1.75 | -0.05 (-2.78%) |
0.45 - 2.98 | 1,602,387 | 1,940,000 | 49,569 | |
03-03-2021 | AH | After the close (Mar 3) |
AMPE | Ampio Pharmaceuticals, Inc. | 318.29 | -0.02 | -0.02 | 0.00 | Ampio Pharmaceuticals EPS in-line [3/3/2021 4:10 PM] |
1.56 | 0.07 (8.74%) |
1.51 | 0.08 (5.59%) |
0.31 - 2.98 | 3,829,083 | 2,871,167 | 127,765 | |
|
||||||||||||||||||
03-11-2020 | AH | 6:00 PM ET (Nov 5) |
AMPE | Ampio Pharmaceuticals, Inc. | 147.34 | -0.02 | -0.02 | -0.05 | Ampio Pharmaceuticals reports Q3 results [11/5/2020 5:17 PM] |
0.8508 | -0.03 (-3.32%) |
0.8620 | -0.02 (-2.05%) |
0.31 - 1.39 | 2,265,013 | 1,243,676 | 45,075 | |
|